These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 22127964)
1. Disparities in renal replacement in lupus nephritis: current practice and future implications. Ishimori ML; Gudsoorkar V; Venuturupalli SR; Weisman MH Arthritis Care Res (Hoboken); 2011 Dec; 63(12):1639-41. PubMed ID: 22127964 [No Abstract] [Full Text] [Related]
2. Variation in initial kidney replacement therapy for end-stage renal disease due to lupus nephritis in the United States. Devlin A; Waikar SS; Solomon DH; Lu B; Shaykevich T; Alarcón GS; Winkelmayer WC; Costenbader KH Arthritis Care Res (Hoboken); 2011 Dec; 63(12):1642-53. PubMed ID: 22058067 [TBL] [Abstract][Full Text] [Related]
3. Sociodemographic and geographic predictors of quality of care in United States patients with end-stage renal disease due to lupus nephritis. Plantinga LC; Drenkard C; Patzer RE; Klein M; Kramer MR; Pastan S; Lim SS; McClellan WM Arthritis Rheumatol; 2015 Mar; 67(3):761-72. PubMed ID: 25692867 [TBL] [Abstract][Full Text] [Related]
4. Neonatal renal replacement therapy: An ethical reflection for a crucial decision. Linder E; Burguet A; Nobili F; Vieux R Arch Pediatr; 2018 Aug; 25(6):371-377. PubMed ID: 30143372 [TBL] [Abstract][Full Text] [Related]
5. Geographic variation in reduced minority representation at dermatology clinics in the Medicare population. Gronbeck C; Feng PW; Feng H J Am Acad Dermatol; 2021 Feb; 84(2):524-526. PubMed ID: 33280902 [No Abstract] [Full Text] [Related]
6. ESRD from lupus nephritis in the United States, 1995-2010. Sexton DJ; Reule S; Solid C; Chen SC; Collins AJ; Foley RN Clin J Am Soc Nephrol; 2015 Feb; 10(2):251-9. PubMed ID: 25534208 [TBL] [Abstract][Full Text] [Related]
7. Ethnicity and access to prescription medicines. Horsburgh S; Norris P N Z Med J; 2013 Oct; 126(1384):7-11. PubMed ID: 24162626 [No Abstract] [Full Text] [Related]
8. European Practice Database in Belgium. Picavet L; Boullé S; De Vos JY; Elseviers M; EDTNA ERCA J; 2006; 32(1):27-32. PubMed ID: 16700165 [TBL] [Abstract][Full Text] [Related]
9. Evolving trends in clinical presentation of and renal replacement therapy for chronic kidney disease. Ansell D; Tomson CR Nephron Clin Pract; 2009; 111(4):c265-7. PubMed ID: 19372707 [No Abstract] [Full Text] [Related]
10. Lupus nephritis: Implications of the new ACR lupus nephritis guidelines. Anders HJ; Appel GB Nat Rev Nephrol; 2012 Sep; 8(9):500-1. PubMed ID: 22825673 [TBL] [Abstract][Full Text] [Related]
11. Geography and ESRD care: what contributes most to hemodialysis patient-provider visit variation? Young B Clin J Am Soc Nephrol; 2013 Jun; 8(6):898-900. PubMed ID: 23749447 [No Abstract] [Full Text] [Related]
12. Hemodialysis patients with hepatitis C infection are not receiving the new antiviral medications. Goodkin DA; Bieber B Am J Nephrol; 2015; 41(4-5):302. PubMed ID: 26044708 [No Abstract] [Full Text] [Related]
13. Racially and ethnically selective oligoanalgesia: is this racism? Goldfrank LR; Knopp RK Ann Emerg Med; 2000 Jan; 35(1):79-82. PubMed ID: 10613944 [No Abstract] [Full Text] [Related]
14. Renal outcome after kidney-transplantation in Korean patients with lupus nephritis. Park ES; Ahn SS; Jung SM; Song JJ; Park YB; Lee SW Lupus; 2018 Mar; 27(3):461-467. PubMed ID: 28799839 [TBL] [Abstract][Full Text] [Related]
15. Reducing health inequity for Māori people in New Zealand. Hobbs M; Ahuriri-Driscoll A; Marek L; Campbell M; Tomintz M; Kingham S Lancet; 2019 Nov; 394(10209):1613-1614. PubMed ID: 31690438 [No Abstract] [Full Text] [Related]